[1]
“Expanding hepatocellular carcinoma surveillance strategies in high-risk patients in Switzerland: a cost-effectiveness analysis”, Swiss Med Wkly, vol. 156, no. 5, p. 4469, May 2026, doi: 10.57187/4469.